Skip to main content
Clinical Trials/NCT06322589
NCT06322589CompletedNot Applicable

Evaluation of Human Efficacy of SOD Like Super Drink

TCI Co., Ltd.2 sites in 1 country50 target enrollmentStarted: March 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
2
Primary Endpoint
the change of Glutathione (GSH) of blood

Study Overview

Brief Summary

To assess the efficacy of SOD like Super Drink on anti-oxidant capacity, immuno regulation and skin for human

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy adults aged between 30-65 years old

Exclusion Criteria

  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder
  • Patients with diseases of the skin, liver, kidney.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 4 weeks.
  • Students who are currently taking courses taught by the principal investigator of this trial.

Arms & Interventions

placebo drink

Placebo Comparator

Intervention: placebo drink (Dietary Supplement)

SOD like Super Drink

Experimental

Intervention: SOD like Super Drink (Dietary Supplement)

Outcomes

Primary Outcomes

the change of Glutathione (GSH) of blood

Time Frame: Change from Baseline GSH at 8 weeks

venous blood was sampled to measure GSH

the change of Superoxide Dismutase (SOD) of blood

Time Frame: Change from Baseline SOD at 8 weeks

venous blood was sampled to measure SOD

the roughness of skin texture

Time Frame: Rating skin roughness from Baseline skin texture at 8 weeks

IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units

the change of skin elasticity

Time Frame: Change from Baseline skin elasticity at 8 weeks

Cutometer® was utilized to measure skin elasticity. Units: arbitrary units

the change of Total Anti-oxidative Capacity (TAC) of blood

Time Frame: Change from Baseline TAC at 8 weeks

venous blood was sampled to measure TAC

the change of Glutathione S-transferase (GST) of blood

Time Frame: Change from Baseline GST at 8 weeks

venous blood was sampled to measure GST

the volume of skin wrinkles

Time Frame: Volume change from Baseline skin wrinkles at 8 weeks

IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units

the change of Malondialdehyde (MDA) of blood

Time Frame: Change from Baseline MDA at 8 weeks

venous blood was sampled to measure MDA

the change of immune-related cytokines of blood

Time Frame: Change from Baseline immune-related cytokines at 8 weeks

venous blood was sampled to measure immune-related cytokines

Secondary Outcomes

  • the change of skin Transepidermal Water Loss (TEWL)(Change from Baseline TEWL at 8 week)
  • the change of skin surface hydration(Change from Baseline skin surface hydration at 8 week)
  • the change of Skin Erythema Index(Change from Baseline skin Erythema Index at 8 week)
  • the change of Skin Melanin Index(Change from Baseline skin Melanin Index at 8 week)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials